UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 72 filers reported holding UROGEN PHARMA LTD in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $11,000 | -8.3% | 1,282 | 0.0% | 0.00% | – |
| Q4 2021 | $12,000 | -45.5% | 1,282 | 0.0% | 0.00% | – |
| Q3 2021 | $22,000 | +10.0% | 1,282 | 0.0% | 0.00% | – |
| Q2 2021 | $20,000 | -20.0% | 1,282 | 0.0% | 0.00% | – |
| Q1 2021 | $25,000 | +8.7% | 1,282 | 0.0% | 0.00% | – |
| Q4 2020 | $23,000 | -8.0% | 1,282 | 0.0% | 0.00% | – |
| Q3 2020 | $25,000 | -24.2% | 1,282 | 0.0% | 0.00% | – |
| Q2 2020 | $33,000 | +43.5% | 1,282 | 0.0% | 0.00% | – |
| Q1 2020 | $23,000 | -46.5% | 1,282 | 0.0% | 0.00% | – |
| Q4 2019 | $43,000 | -25.9% | 1,282 | -47.0% | 0.00% | – |
| Q3 2019 | $58,000 | -33.3% | 2,421 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $87,000 | -2.2% | 2,421 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $89,000 | +81.6% | 2,421 | +112.6% | 0.00% | – |
| Q4 2018 | $49,000 | -9.3% | 1,139 | 0.0% | 0.00% | – |
| Q3 2018 | $54,000 | -5.3% | 1,139 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $57,000 | – | 1,139 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 1,252,285 | $24,156,000 | 7.72% |
| Horton Capital Management, LLC | 375,428 | $7,242,000 | 6.96% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,954,699 | $56,996,000 | 1.27% |
| Phoenix Holdings Ltd. | 901,979 | $16,405,000 | 0.69% |
| SHIKIAR ASSET MANAGEMENT INC | 44,550 | $859,000 | 0.33% |
| Coastal Bridge Advisors, LLC | 37,000 | $714,000 | 0.22% |
| Migdal Insurance & Financial Holdings Ltd. | 738,302 | $14,242,000 | 0.20% |
| Clal Insurance Enterprises Holdings Ltd | 529,388 | $10,212,000 | 0.17% |
| Vivaldi Capital Management LP | 10,000 | $233,000 | 0.05% |
| MEITAV INVESTMENT HOUSE LTD | 48,407 | $934,000 | 0.05% |